116 related articles for article (PubMed ID: 37670696)
1. Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cells by Regulating the AKT/FOXO1 Pathway.
Jiang J; Zhang C; Wang J; Zhu Y; Wang X; Mao P
Anticancer Agents Med Chem; 2023; 23(19):2127-2134. PubMed ID: 37670696
[TBL] [Abstract][Full Text] [Related]
2. Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1.
Hoekstra AV; Ward EC; Hardt JL; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
Gynecol Oncol; 2008 Mar; 108(3):609-18. PubMed ID: 18234299
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HEIH Enhances Paclitaxel-Tolerance of Endometrial Cancer Cells via Activation of MAPK Signaling Pathway.
Guo JL; Tang T; Li JH; Yang YH; Zhang L; Quan Y
Pathol Oncol Res; 2020 Jul; 26(3):1757-1766. PubMed ID: 31650338
[TBL] [Abstract][Full Text] [Related]
4. Fucoxanthin prevents cell growth and induces apoptosis in endometrial cancer HEC-1A cells by the inhibition of the PI3K/Akt/mTOR pathway.
Qu J; Sun Y; Yang L; Niu X; Li L
J Biochem Mol Toxicol; 2022 Jun; 36(6):e23027. PubMed ID: 35266250
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Expression of the S100A8 Gene Encoding the S100 Calcium-Binding Protein A8 Promotes Apoptosis by Suppressing the Phosphorylation of Protein Kinase B (Akt) in Endometrial Carcinoma and HEC-1A Cells.
Liu C; Xing G; Wu C; Zhu J; Wei M; Liu D; Ge Y; Chen Y; Lei T; Yang Y
Med Sci Monit; 2018 Mar; 24():1836-1846. PubMed ID: 29595187
[TBL] [Abstract][Full Text] [Related]
6. SMC4 knockdown inhibits malignant biological behaviors of endometrial cancer cells by regulation of FoxO1 activity.
Yan Y; Liu C; Zhang J; Li W; Yin X; Dong L; Pang S; Li X
Arch Biochem Biophys; 2021 Nov; 712():109026. PubMed ID: 34506757
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity to paclitaxel-induced apoptosis and growth suppression in paclitaxel-resistant cell lines established from HEC-1 human endometrial adenocarcinoma cells.
Tanaka T; Toujima S; Tanaka J
Int J Oncol; 2012 Nov; 41(5):1837-44. PubMed ID: 22923148
[TBL] [Abstract][Full Text] [Related]
8. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.
Goto T; Takano M; Albergaria A; Briese J; Pomeranz KM; Cloke B; Fusi L; Feroze-Zaidi F; Maywald N; Sajin M; Dina RE; Ishihara O; Takeda S; Lam EW; Bamberger AM; Ghaem-Maghami S; Brosens JJ
Oncogene; 2008 Jan; 27(1):9-19. PubMed ID: 17599040
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway.
Li G; Xu D; Sun J; Zhao S; Zheng D
Adv Clin Exp Med; 2020 Nov; 29(11):1337-1345. PubMed ID: 33269821
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
[TBL] [Abstract][Full Text] [Related]
11. Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer
O'Donnell J; Zhao Z; Buckingham L; Hao T; Suo H; Zhang X; Fan Y; John C; Deng B; Shen X; Sun W; Secord AA; Zhou C; Bae-Jump VL
Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37503790
[TBL] [Abstract][Full Text] [Related]
12. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
Zhang S; Wang M; Li Q; Zhu P
Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
[TBL] [Abstract][Full Text] [Related]
13. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.
Ward EC; Hoekstra AV; Blok LJ; Hanifi-Moghaddam P; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
Endocrinology; 2008 Apr; 149(4):1942-50. PubMed ID: 18096667
[TBL] [Abstract][Full Text] [Related]
14. CEP55 predicts the poor prognosis and promotes tumorigenesis in endometrial cancer by regulating the Foxo1 signaling.
Zhang X; Xu Q; Li E; Shi T; Chen H
Mol Cell Biochem; 2023 Jul; 478(7):1561-1571. PubMed ID: 36434144
[TBL] [Abstract][Full Text] [Related]
15. Circ_0039569 contributes to the paclitaxel resistance of endometrial cancer via targeting miR-1271-5p/PHF6 pathway.
Li J; Zhang Z; Hu Y; Wei Q; Shao X
Anticancer Drugs; 2022 Oct; 33(9):883-892. PubMed ID: 36136988
[TBL] [Abstract][Full Text] [Related]
16. Combination effects of paclitaxel with signaling inhibitors in endometrial cancer cells.
Xu C; Li X; Li T; Wang X; Yang Y; Xiao L; Shen H
Asian Pac J Cancer Prev; 2011; 12(11):2951-7. PubMed ID: 22393970
[TBL] [Abstract][Full Text] [Related]
17. MiR-196a-5p facilitates progression of estrogen-dependent endometrial cancer by regulating FOXO1.
Zhu Y; Tang Y; Fan Y; Wu D
Histol Histopathol; 2023 Oct; 38(10):1157-1168. PubMed ID: 36573636
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of cyclophilin A reverses paclitaxel resistance in human endometrial cancer cells via suppression of MAPK kinase pathways.
Li Z; Min W; Gou J
Cancer Chemother Pharmacol; 2013 Nov; 72(5):1001-11. PubMed ID: 24036847
[TBL] [Abstract][Full Text] [Related]
19. HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer.
Wang W; Jiang X; Xia F; Chen X; Li G; Liu L; Xu Q; Zhu M; Chen C
Mol Biol Rep; 2023 Jan; 50(1):453-464. PubMed ID: 36348197
[TBL] [Abstract][Full Text] [Related]
20. Metadherin inhibits chemosensitivity of triple-negative breast cancer to paclitaxel via activation of AKT/GSK-3β signaling pathway.
Chang Y; Jia HQ; Xu B; Yang L; Xu YT; Zhang JY; Wang MQ; Yang LX; Song ZC
Chem Biol Drug Des; 2024 Jan; 103(1):e14416. PubMed ID: 38093418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
